arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Scilex Holding Co

SCLX
$7.02 ▲ +0.14 (+2.11%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
6 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
73
Health
Good
Bullish
auto_awesome

Analytical Summary

Scilex Holding Co shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth -46.5%
Op. Margin None
ROIC 166.5%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

6-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$30.25M
↓ -46.5%
Net Income Profit after all expenses
$-374.05M
↓ -413.8%
Operating Margin Operating profit as % of sales
-147.4%
↑ +34.7%
FCF / Share Free cash flow per share
$0.15
↑ +192.7%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
66
Returns
100
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 25 quarters